Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

394041424344454647

AstraZeneca, Daiichi Sankyo cancer drug secures US regulatory boost

27th Apr 2022 09:44

(Alliance News) - AstraZeneca PLC on Wednesday said a cancer drug it has helped develop to treat a form of breast cancer has been granted breakthrough therapy designation in the US. Read More

AstraZeneca's Tremelimumab-Imfinzi combo to get US priority review

25th Apr 2022 08:32

(Alliance News) - AstraZeneca PLC on Monday announced its candidate for unresectable liver cancer Tremelimumab has been accepted under priority review by the US Food & Drug Administration. Read More

LONDON MARKET PRE-OPEN: British Land sells Paddington Central stake

25th Apr 2022 07:50

(Alliance News) - Stock prices in Europe are seen opening lower on Monday, with a grim Covid-19 situation in China adding to a mountain of worries for equities investors, which included hawkish comments made by Federal Reserve Chair Jerome Powell late last week. Read More

UK earnings, trading statements calendar - next 7 days

22nd Apr 2022 16:03

Read More

UK shareholder meetings calendar - next 7 days

22nd Apr 2022 16:01

Read More

AstraZeneca says no severe virus cases or deaths after taking antibody

21st Apr 2022 06:01

(Alliance News) - AstraZeneca PLC late Wednesday said a clinical trial found its Evusheld antibody therapy markedly reduced the risk of developing symptomatic Covid-19. Read More

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

20th Apr 2022 10:00

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause. Read More

LONDON BROKER RATINGS: Prudential and CRH get upgrades, ITV cut

19th Apr 2022 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Thursday last week: Read More

AstraZeneca's Enhertu wins priority review by FDA for lung cancer

19th Apr 2022 08:17

(Alliance News) - AstraZeneca PLC on Tuesday said its lung cancer antibody drug conjugate Enhertu has received priority review from the Food & Drug Administration in the US. Read More

LONDON MARKET PRE-OPEN: Spectris launches GBP300 million share buyback

19th Apr 2022 07:44

(Alliance News) - Stock trading in London is set for a downbeat return following the long Easter weekend, with traders mulling global growth prospects. Read More

LONDON BROKER RATINGS: BofA raises Rightmove; Berenberg cuts Bunzl

14th Apr 2022 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon: Read More

LONDON BROKER RATINGS: JPMorgan lowers Rolls-Royce; UBS likes Ryanair

12th Apr 2022 10:11

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

LONDON BROKER RATINGS: Jefferies cuts TI Fluid, PageGroup, Energean

7th Apr 2022 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

AstraZeneca notes positive follow-up results for Ultomiris

6th Apr 2022 20:57

(Alliance News) - AstraZeneca PLC said on Wednesday new, prolonged follow-up results from the phase three Champion-MG trial showed that Ultomiris demonstrated long-term efficacy in adults with generalised myasthenia gravis. Read More

LONDON BROKER RATINGS: Berenberg cuts Polymetal and raises Hochschild

6th Apr 2022 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

AstraZeneca's AZD8233 shows positive results for hypercholesterolemia

5th Apr 2022 07:00

(Alliance News) - AstraZeneca PLC announced positive results from its Etesian phase IIb trial on Monday, which met its primary and secondary endpoints. Read More

AstraZeneca's Ondexxya approved in Japan to treat major bleeds

29th Mar 2022 07:48

(Alliance News) - AstraZeneca PLC on Tuesday said its reversal agent Ondexxya has been fully approved in Japan for reversal of acute major bleeds in some patients. Read More

TOP NEWS: AstraZeneca's Evusheld backed in EU for Covid-19 prevention

28th Mar 2022 07:21

(Alliance News) - AstraZeneca PLC said on Monday that its Evusheld antibody combination for Covid-19 prevention has been granted marketing authorization in the EU. Read More

LONDON MARKET PRE-OPEN: Barclays warns of hit; Astra Covid drug backed

28th Mar 2022 06:47

(Alliance News) - Stock prices in London are seen opening ever-so slightly higher on Monday in a cautious start to the new week, with markets tracking geopolitical developments and rising Covid-19 cases in China, while also awaiting fresh drivers in a quiet day in the economic calendar. Read More

UPDATE: EU drug watchdog approves AstraZeneca Covid prevention jab

24th Mar 2022 20:28

(Alliance News) - The EU's drug watchdog on Thursday recommended for approval AstraZeneca PLC's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. Read More

394041424344454647
FTSE 100 Latest
Value9,527.65
Change20.24